A61K 38/1706
From fish
Official title: {from fish}
A61K38/1706 (From fish) appears on 48 US grants and 79 published applications in this corpus.
Search patents in A61K- Granted patents
- 48
- Published applications
- 79
- Assignees
- 52
- Inventors
- 120
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 3 |
| 2011 | 3 | 4 |
| 2012 | 1 | 4 |
| 2013 | 4 | 0 |
| 2014 | 0 | 4 |
| 2015 | 2 | 3 |
| 2016 | 3 | 10 |
| 2017 | 4 | 5 |
| 2018 | 6 | 3 |
| 2019 | 6 | 6 |
| 2020 | 3 | 7 |
| 2021 | 4 | 3 |
| 2022 | 4 | 6 |
| 2023 | 2 | 5 |
| 2024 | 2 | 5 |
| 2025 | 2 | 1 |
| 2026 | 1 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition and methods for activating cellular signaling genes in innate inflammatory pathways31 Mar 2026US 12,589,067 B2LifeVantage Corporation
- Piscine-derived PYY peptides for use in treating a metabolic disorder30 Dec 2025US 12,508,295 B2University of Ulster
- Stapled intracellular-targeting antimicrobial peptides to treat infection19 Aug 2025US 12,391,733 B2Dana-Farber Cancer Institute, Inc.
- Stapled intracellular-targeting antimicrobial peptides to treat infection2 Apr 2024US 11,945,846 B2Dana-Farber Cancer Institute, Inc.
- Trypsin isoforms and their use5 Mar 2024US 11,918,674 B2Enzymatica AB
- Use of hemolymph or hemolymph components for the treatment and prevention of inflammation and dry skin13 Aug 2026US 2026/0232761 A1Marin Brands Inc.
- Polypeptide and use thereof in promoting muscle hyperplasia and enhancing physical exercise performance13 Aug 2026US 2026/0234200 A1Greenyn Biotechnology Co., Ltd
- Piscine-derived pyy peptides for use in treating a metabolic disorder16 Jul 2026US 2026/0199429 A1University of Ulster
- Composition and methods for activating cellular signaling genes in innate inflammatory pathways18 Jun 2026US 2026/0165357 A1LifeVantage Corporation
- Methods for increasing type i, iii, and v collagen in an animal7 May 2026US 2026/0124272 A1Societe des Produits Nestle S. A.
Most cited
By later US patents
- Process for controlling protein to salt ratio in animal muscle protein composition and protein composition11US 7,956,081 B2Proteus Industries, Inc. · 2011
- Innoxious interferon-inducing substance, inducing agent and process for producing same5US 4,323,496 A1982
- Treatment for obesity3US 8,076,291 B2Unigene Laboratories Inc. · 2011
- Treatment for obesity3US 8,217,139 B2Unigene Laboratories Inc. · 2012
- Methods of treating medical conditions using peptides3US 8,497,347 B2UGP Therapeutics, Inc. · 2013